Expert Speaker Faculty

Take a look at the esteemed speaker faculty for the 6th Operationalize Expanded Access Programs Summit.

Pharma Thought Leaders
Biotech Thought Leaders
Patient & Advocacy Voices
Trusted Partners

Pharma Thought Leaders

Cristan Argueta

Cristian Argueta

Director - Market Access
AstraZeneca
Sara Radenovic

Sara Radenovic

Director, Managed Access Programs
Bristol Myers Squibb
Michael Bethel

Michael Bethel

Executive Director - Managed Access, Medical Evidence Generation & Programs Lead
Bristol Myers Squibb
Annie Drelles

Annie Drelles

Senior Director - Medical Access, Global Oncology Medical Affairs
Daiichi Sankyo
Gretchen Randlett

Gretchen randlett

Executive Director & Consultant - Expanded, Continued Access, Product Delivery, Clinical Trial Commercial Product Strategy & Pr
Eli Lilly & Co.
Leigh Ann Durant

Leigh Ann Durant

Head of Governance
EMD Serono
Christine Istanboulian

Christine istanboulian

Senior Global Manager, Managed Access Programs
Sanofi
Jamie Sommer

Jamie Sommer

Senior Manager - Global Clinical Supply Chain
Takeda Pharmaceutical

Biotech Thought Leaders

David Setbourn

David Setboun

Chief Operating Officer
Alkeus Pharmaceuticals, Inc.
Bethany Bearden

Bethany Bearden

Assoc Director EAP
Blueprint Medicines
Kjersten Teeter

Kjersten Teeter

Director, Head of Global Medical Operational Excellence and Strategic Planning
Blueprint Medicines
Stephen Smith

Stephen Smith

Senior Director - Program & Oncology
Corcept Therapeutics Incorporated
Eleana Hardy

Eleana Hardy

Head, Global Independent Medical Education, Investigator Sponsored Trials & US Expanded Access Program
Jazz Pharmaceuticals plc
Jennifer mclaughlin

Jennifer Mclaughlin

Associate Director & Senior Manager - Medical Affairs, Global IST Operations, Investigator Sponsored Trial & EAP Operations
Jazz Pharmaceuticals plc
Kent Christopherson

Kent Christopherson

Global Medical Affairs Head
Orchard Therapeutics
Sheila Wilson

Sheila Gilbride-Wilson

Vice President, Clinical Operations & Data Management
Orchard Therapeutics
David Stein

David Stein

Senior Director - Clinical Trial Management
Regeneron Pharmaceuticals
Maggie Loughran

Maggie Loughran

Associate Manager - Medical Study Operations
Regeneron Pharmaceuticals
Michele Rhee

Michele Rhee

Vice President - Global Advocacy Relations & Patient Engagement
Savara Pharmaceuticals
Martha Kennedy

Martha Kennedy

Director - Early Access Program
Scholar Rock Holding Corporation
Palak Argawal

Palak Agarwal

Associate Director - Global Medical Strategy & Operations
Scholar Rock Holding Corporation
Stanley Kim

Stanley Kim

Chief Executive Officer
WinSanTor Inc.

Patient & Advocacy Voices

Harpreet Ram

Harpreet Ram

Principal
GARDaccess
Richard Klein

Richard Klein

Director - Expanded Access Programs & Policy
GE2P2 Global Foundation
Michael Wrigglesworth

Michael Wrigglesworth

Vice President - Programs Operations
The Max Foundation

Trusted Partners

Dennis Akkaya

Dennis Akkaya

Chief Commercial Officer (Cco)
myTomorrows
Event image
Explore the Agenda

Uncover practical insights from leading access, operations, and medical affairs experts through real-world case studies, interactive discussions, and hands-on workshops designed to help you build, manage, and scale compliant, patient-focused Expanded Access Programs worldwide

View Presentations & Speakers
Event image
Partner With Us

Showcase how your solutions empower sponsors to operationalize access - from supply chain and digital workflow tools to regulatory consultancy and real-world data systems

Explore Sponsorship Options
Event image
Join the Global EAP Community

Be part of the only meeting uniting 140+ access leaders across pharma, biotech, and service providers. Exchange practical experience, shape global best practices, and collaborate on solutions that advance equitable, ethical, and scalable access for patients in need

.

Register Now